ROIC_ NEW logo_blue text transparent background.png
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
11 juin 2024 09h00 HE | Retail Opportunity Investments Corp.
Retail Opportunity Investments Corp. Schedules Second Quarter Earnings Release and Conference Call
Agios_2021_Logo.png
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
06 juin 2024 09h00 HE | Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Alterity.png
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 mai 2024 19h21 HE | ALTERITY THERAPEUTICS LIMITED
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May ...
Arbutus Biopharma Logo
Arbutus to Participate in Jefferies Global Healthcare Conference
29 mai 2024 07h30 HE | Arbutus Biopharma Corporation
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Logo.jpg
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
28 mai 2024 16h07 HE | UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
micron-logo_black_rgb.png
Micron Technology to Report Fiscal Third Quarter Results on June 26, 2024
28 mai 2024 16h01 HE | Micron Technology, Inc.
BOISE, Idaho, May 28, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal third quarter earnings conference call on Wednesday, June 26, 2024,...
Optinose_logo_RGB.png
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
17 mai 2024 12h00 HE | Optinose, Inc.
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Cavco_Logo.png
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Fourth Quarter and Year End Earnings Release and Conference Call Webcast
15 mai 2024 20h50 HE | Cavco Industries, Inc.
PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended March 30, 2024 on Thursday, May 23, 2024 after the...
Optinose_logo_RGB.png
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
14 mai 2024 07h00 HE | Optinose, Inc.
Company reports Q1 2024 XHANCE net revenue of $14.9 million, an increase of 26% compared to Q1 2023 Company expects full year 2024 XHANCE net revenues to be between $85.0 to $95.0 million ...
LOGO ND NW.png
Nano Dimension Announces Q1/2024 Conference Call to Discuss Quarterly Results
13 mai 2024 08h00 HE | Nano Dimension Ltd.
Participants Are Welcome to Listen June 3rd at 9:00 am ET Waltham, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading...